A Study of XW003 Injection in Chinese Adolescents With Obesity

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 25, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions

Obese AdolescentsObesity

Interventions

DRUG

XW003 injection

Subcutaneous injection

DRUG

placebo with matching volume

Subcutaneous injection

Trial Locations (1)

RECRUITING

Qilu Hospital of Shandong University, Jinan

All Listed Sponsors

lead

Hangzhou Sciwind Biosciences Co., Ltd.

INDUSTRY

NCT07143227 - A Study of XW003 Injection in Chinese Adolescents With Obesity | Biotech Hunter | Biotech Hunter